2022 Speakers
Peter Abbink, Head of R&D - Director of Operations, Batavia Biosciences
Brian Abramson, Vaccine Law Expert, Brian Dean Abramson, Esq.
Nicholas Abuid, Application Scientist, ACROBiosystems Inc.
Ruchir Agarwal, Economist, Head Global Health & Pandemic Response Taskforce, IMF
Hansilla Alaigh, Senior Director, Vaccine Global Program, Clover Biopharmaceuticals
Sally Allain, Head, JLABS at Washington DC, Johnson & Johnson Innovation
Heather Allen, Homeland and National Security Policy Analyst, USDA
Galit Alter, Associate Professor Of Medicine, Harvard Medical School
Stephen Angeloni, Genomics Field Application Scientist, Luminex Corporation
Khursheed Anwer, CSO, Celsion Corporation
Joann Arce, Instructor in Pediatrics, Harvard Medical School
Phyllis Arthur, Vice President, Infectious Diseases and Emerging Science Policy, Biotechnology Innovation Organization (BIO)
Stephen Auvil, Chief Program Operations Officer, Tedco
Lindsay Robert Baden, Associate Professor, Brigham and Women's Hospital Associate Professor of Medicine, Harvard Medical School, Brigham and Women's Hospital
Anthony Baffoe-Bonnie, Infectious Diseases Division, Carilion Clinic
Priya Bahri, Principal Scientific Officer, European Medicines Agency
Zane Baird, Research Scientist I, Baxter BioPharma Solutions
Dan Barouch, Professor Of Medicine, Harvard Medical School
Nasir Bashiruddin, CTO, OriCiro Genomics
Alina Baum, Director, Infectious Diseases, Regeneron Pharmaceuticals
Norman Baylor, Former Director, Office of Vaccines Research and Review/CBER, FDA; President & Chief Executive Officer, Biologics Consulting
Roy Baynes, Senior Vice President Clinical Research, Merck Research Laboratories
Thomas Beadnell, Scientific Manager, Eurofins Viracor Biopharma
Loren Becker, Associate Principal, Avalere Health
Ghiorghis (George) Belai, Vice President of Global Strategy, FHI Clinical
Dan Bell, Senior Vice President, Innovation & Strategic Operations, Marken
Jesse Bendetson, Medical Student, Virginia Tech Carilion School of Medicine
Laura Benjamin, Founder And Chief Executive Officer, OncXerna
Sharon Benzeno, Chief Commercial Officer, Immune Medicine, Adaptive Biotechnologies
Francesco Berlanda Scorza, Director GVGH, GSK Vaccines for Global Health (GVGH)
Valentina Bernasconi, Scientist, CEPI
Jay Berzofsky, Branch Chief, Vaccine Branch, National Cancer Institute - NIH
Mike Bhaskaran, Chief Operating Officer of Digital Technology, DP World
Alexandra Bhatti, Director, Merck
John Billington, Head of Health Security and Infectious Disease Policy and Advocacy, GSK
Vince Blaser, Director, Advocacy and Outreach, Vaccine Acceptance and Demand, Sabin Vaccine Institute
April Blodgett, Sales, InDevR
Dr Karin Bok, Director of Pandemic Preparedness and Emergency Response, Vaccine Research Center, NIAID, NIH
Cyrille Bonhomme, Director, Laboratory Services, Vaccine Sciences Lab, PPD, part of Thermo Fisher Scientific
Anthony Bostick, Head Vaccine Operations, DLA
Maria Elena Bottazzi, Co-Director, Texas Children’s Hospital Center for Vaccine Development, Baylor College of Medicine
Abby Bownas, Partner, AVAC
Harry Brady, Executive Director, International Vaccines Public Policy, MSD
Jacob Braude, Principal, ZS Associates
David Broniatowski, Director, The George Washington University
Grayson Brown, Executive Director Of The Puerto Rico Vector Control Unit, CDC
Jane Buckner, President, Benaroya Research Institute
Paul Burton, CMO, Moderna
Lynlee Burton, Vice President, Clinical Development - Vaccines, Syneos Health
James Campbell, Professor, University Of Maryland, Center For Vaccine Development and Global Health
Christa Capozzola, Chief Financial Officer, CDC
Libuse Cappellano, Executive Director Project Delivery Vaccines, PPD, part of Thermo Fisher Scientific
Lisa Caproni, Head of Vaccine Discovery, Touchlight
Paula Casasco, Quality & Training Director, VaxTrials
andrew catchpole, CSO, hVIVO
Don Chen, President/Chief Executive Officer, SynAm Vaccine
Roman Chicz, Associate Vice President And Global Head Of External Research And Development, Sanofi
Mohit Chopra, COVID-19 Vaccine Project Lead, Johnson & Johnson
Dennis Christensen, Head Of Vaccine Adjuvant Research Grp., Dept. Infectious Disease Immunology, Statens Serum Institut – Denmark
Amy Chung, Laboratory Head, The Peter Doherty Institute For Infection and Immunity
Christy Comeaux, Medical Lead, Janssen Vaccines and Prevention B.V.
Tim Cooke, CEO, Omniose
Vincent Corvest, Senior Scientist, CALIXAR
Peter Costa, U.S. Medical Affairs Regional Lead, Bavarian Nordic
Rebecca Coyle, Executive Director, American Immunization Registry Association
James Crowe, Director, Vanderbilt Vaccine Center
Rea Dabelic, Market Development Manager, 10x Genomics
Dana Dallas, Cold Chain Program Manager, Defense Logistics Agency
Heath Damron, Director, Vaccine Development Center, Vaccine Development Center at West Virginia University School of Medicine
Barry Datlof, Chief, Business Development and Commercialization, U.S. Army Medical Research and Development Command
Kourtney Davis, Vice President, Global Epidemiology, Janssen Research & Development
Michel de Baar, Executive Director, BD&L Europe, MSD
Annie De Groot, Chief Executive Officer, EpiVax
Mike de Leeuw, Chief Executive Officer, MyLife Technologies BV
Kristen Deger, Senior Research Associate, Evidera, PPD, part of Thermo Fisher Scientific
Kerry DeMarco, DRIVe Start Program Innovation & Alliance Manager, BARDA
Cynthia Derdeyn, Professor, Emory University
Sandrine Dessoy, Expert Scientist, GlaxoSmithKline
Francisco Diaz-Mitoma, CMO, VBI Vaccines
Javier Diez-Domingo, Head of the Vaccine Research Department, Pratia
Nicole A Doria-Rose, Chief of the Humoral Immunology Core, VRC, National Institute of Health - NIAID
Macaya Douoguih, Head, Janssen Clinical Development and Medical Affairs, Janssen Vaccines & Prevention B.V.
Matthew Downham, Director, CEPI
Alexander Doxiadis, Associate Director Cold Chain and Logistics for Vaccine, Clinton Health Access Initiative (CHAI)
Vincent Drouillon, Vice President Of Global Testing Services And Medical Affairs, Labcorp Drug Development
Anna Durbin, Professor, Johns Hopkins Bloomberg School of Public Health
Nathan Duval, Team Lead, NTx
Chris Earnhart, Chief Technology Officer, JPEO-CBRND
Vanessa Elharrar, VP, Vaccine Business Strategy Lead, PPD, part of Thermo Fisher Scientific
Mark Emalfarb, Chief Executive Officer, Dyadic International Inc
Mark Esser, Vice President, Early Vaccines and Immune Therapies, AstraZeneca
Deshayne Fell, Associate Professor, Epidemiology And Public Health, University of Ottawa
Steven Ferguson, Special Advisor, NIH Office of Technology Transfer
Jennifer Filbey, Chief Executive Officer, Mazen Animal Health
Doran Fink, Deputy Director – Clinical, FDA
Robert Fisher, Senior Advisor for CBRN and Pandemic Influenza, Office of Counterterrorism and Emerging Threats (OCET), Food and Drug Administration (FDA)
David Fitter, Branch Chief, Immunization Systems Branch, CDC
Martin Friede, Coordinator, Initiative For Vaccine Research Immunization, Vaccines And Biologicals Department, World Health Organisation
Leonard Friedland, Vice President Of Scientific Affairs And Public Health Vaccines, GSK
Kevin Fu, Associate Professor, University of Michigan
Luc Gagnon, Vice President, Vaccine Sciences, Nexelis, a Q² Solutions Company
Rachelle Galvin, Chief Operating Officer, Resilient Biotics
Cyril Gay, Senior National Program Leader, A.R.S. National Programs
Bruce Gellin, President Global Immunization, Sabin Vaccine Institute
Dr Elvin Geng, Professor Of Medicine, Washington University
Rebecca Gentile, Associate Director, Merck
Volker Gerdts, Director And Chief Executive Officer, VIDO
Philippe-Alexandre Gilbert, Senior Program Officer CMC, The Bill & Melinda Gates Foundation
Ann Ginsberg, Deputy Director, B.M.G.F.
Trang Gisler, Senior Director, Strategy, Government and Public Health Services, PPD, part of Thermo Fisher Scientific
Douglas Gladue, Senior Scientist, Plum Island Animal Disease Center, USDA
Amanda Glassman, EVP & Senior Fellow, Center for Global Development
Gregory Glenn, President, Research And Development, Novavax
Cynthia Ann Gómez, Professor Emeritus, San Francisco State University, University of California, San Francisco
Brown Grayson, Executive Director, Puerto Rico Vector Control Unit
Beth Ann Griswold-Coller, Executive Director, Vaccines Clinical Research, Merck Research Laboratories
Jan Groen, Chief Executive Officer, Intravacc
Dr Duane Gubler, Professor Emeritus, Duke-NUS Graduate Medical School
Farshad Guirakhoo, Chief Scientific Officer, Vaxxinity
Swati Gupta, Vice President, Research Integration And Innovation, International Aids Vaccine Initiative
Anuradha Gupta, Deputy Chief Executive Officer, Gavi
Vikas Gupta, Director, MMS Medical Affairs, BD Insights Life Sciences
Javier Guzman, Director, Center for Global Development
Jason Hall, Managing Director, Policy, Avalere Health LLC
Melinda Hamer, Deputy Director, Operations, Congressional Directed Medical Research Programs, USAMRDC
Scott Hamilton Kennedy, Director, Black Valley Films
LaTreace Harris, Team Lead, Lead Health Scientist Evaluation and Applied Analytics Team, Centers for Disease Control and Prevention
Kathryn Hashey, Director, GSK
Mateusz Hasso-Agopsowicz, Technical Officer, World Health Organization
Sabine Hauck, SVP Corporate Development, Leukocare AG
Bill Hearl, Chief Executive Officer, Immunomic Therapeutics
colin hebert, vp biotech, lumacyte
Charles Heffernan, Director, C.R.B.
Jon Heinrichs, AVP, Sanofi
Jenny Hendriks, Head Biomarkers, Janssen Vaccines & Prevention B.V.
Lisa Hensley, Associate Director, National Institute of Health
Matthew Hepburn, Program Manager, White House Office Of Science And Technology Policy (OSTP)
David Hipkiss, Chief Executive Officer, Enesi Pharma Limited
Stephen Hoffman, Chief Executive And Scientific Officer, Sanaria
Scott Holmstrom, Senior Vice President, United Animal Health
Axel Hoos, Chief Executive Officer, Scorpion Therapeutics
Camille Hopkins, Wildlife Disease Coordinator, USGS
Kate Hopkins, Director of Research, Vaccine Acceptance & Demand, Sabin Vaccine Institute
Peter Hotez, Dean, National School Of Tropical Medicine, Co-Director, Texas Children's Hospital Center, Baylor College of Medicine
Vivian Hsu, Deputy Director Strategy Planning and Management, Vaccine Development & Surveillance, The Bill & Melinda Gates Foundation
Randall Hyer, Professor, The Baruch S. Blumberg Institute
Flonza Isa, Associate Medical Director, Regeneron Pharmaceuticals
Hector Izurieta, Associate Director, Novel Clinical Investigations OVRR/CBER, U.S. Federal Drug Administration
Hasan Jafri, Chief Medical Officer and Head of Clinical Development, Aridis Pharmaceuticals
Robert Janssen, Chief Medical Officer, Dynavax Technologies
Jose Jimeno, Chief Executive Officer, VaxTrials
Michael Kalos, Managing Director, Next Pillar Consulting
Patrick Kamba, Executive Director, Vaccines, Global Project Management, PPD, part of Thermo Fisher Scientific
Masaru Kanekiyo, Cheif, Molecular Immunoengineering Section, National Institutes of Health
Vivek Kapur, Professor of Microbiology and Infectious Diseases, Huck Distinguished Chair in Global Health, Huck Institutes of the Life Sciences
David C Kaslow, Chief Scientific Officer, PATH
Johanna Kaufmann, EVP Oncology, Codagenix, Inc.
Pravin Kaumaya, Professor and Director Vaccine Research, The Ohio State University Werner Medical Center
Richard Kennedy, Professor Of Medicine, Co-Director, Mayo Vaccine Research Group, Mayo Clinic
Andrew Kilianksi, Senior Director, Emerging Infectious Diseases, IAVI
Kevin Killeen, Chief Scientific Officer, Matrivax R & D Corp
Joseph Kim, Chief Executive Officer, Inovio Pharmaceuticals
David Kim, Director, Division of Vaccines, Assistant Secretary for Health, HHS
Jerome Kim, Director General, International Vaccine Institute
Denny Kim, SVP, Chief Safety Officer, Novavax
Radife Kiral, NA Vaccines Regional President, Pfizer
Jelle Klein, Associate Medical Director, SGS Health Science
Charles Kline, Distinguished Scientist, Merck
Keith Klugman, Director, Bill & Melinda Gates Foundation
Ivana Knezevic, Scientist, Team Leader, WHO
Stacey Knobler, Vice President, Vaccine Innovation & Global Immunization, Sabin Vaccine Institute
Sonali Kochhar, Clinical Associate Professor, Department of Global Health, University of Washington
Wayne Koff, President And Chief Executive Officer, The Human Vaccines Project
Angela Kogler, SVP, Medical Strategy, 21GRAMS
Jan Komrska, Contract Manager, UNICEF
John Korslund, One Health Coordinator (Acting), USDA
Steve Kosteski, Vice President – Global BioPharm, IsoPlexis
Richard Koup, Deputy Director, Vaccine Research Center, Chief, Immunology Laboratory And Immunology Section, National Institute of Health - NIAID
Philip Krause, Advisor, WHO
Hatice Küçük, Executive Director, The G20 Health and Development Partnership
Greg Kulnis, VP Customer Solutions, Nexelis, a Q² Solutions Company
Mahesh Kumar, Senior VP, Global Biologics, Zoetis
Peter Kwong, Chief, Structural Biology Section, National Institute of Health - NIAID
Michael Lacy, Senior Immunology Consultant, Seneca Therapeutics
Tom Lake, SVP, Strategic Alliances & Commercialization, Vaxxas
Hussain Lalani, Primary Care Internist and Health Policy Researcher, ThisIsOurShot – VacunateYa
Ellen Lawrence, Senior Director, Emergent BioSolutions
Sherry Layton, Chief Scientific Officer, Vetanco Sa
Marie-Liesse Le Corfec, Lead, Global Cross-BU Task Force Supporting Covid-19 Pharma Developments, BD Medical
Alexandre Le Vert, Chief Executive Officer, OSIVAX
Brett Leav, Head, Clinical Development, Public Health Vaccines, Moderna
Carmen Ledesma-Feliciano, Clinical Device Specialist, PharmaJet
Wolfgang Leitner, Chief, Innate Immunity Section, National Institute of Health - NIAID
Marianne Lereuz-Ville, Consultant, Université Paris Descartes
Bennett Levitan, Senior Director, Benefit-Risk Assessment, Global Epidemiology, Janssen Research and Development
Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital Harvard Medical School
Rupali Limaye, Deputy Director, International Vaccine Access Center,, Johns Hopkins Bloomberg School of Public Health
Bengt Johansson Lindbom, CSO, MinervaX
Matt Linley, Lead Analyst, Airfinity Ltd
Amanda Love, Joint Product Manager, JPEO-CBRND
Maria Beatriz Lucchesi, Pharmacovigilance Manager, Instituto Butantan
Nicole Lurie, Director, CEPI-US
Bruce Lyday, Chief Executive Officer, Coronavax LLC
Anne Lyerly, Professor, University Of North Carolina
Rebecca Lynch, Assistant Professor, The George Washington University
Catriona MacDonald, Board Member; Founder and President, Linchpin Strategies, Sepsis Alliance
Noni Macdonald, Professor Of Paediatrics, Canadian Centre For Vaccinology, Dalhousie University
Cal Maclennan, Senior Program Officer for Bacterial Vaccines, Global Health – Enteric and Diarrheal Diseases, Bill and Melinda Gates Foundation
Suman Mahan, Research Director, Zoetis
Kutub Mahmood, Project Director, PATH
Bonnie Maldonado, Professor of Pediatrics and of Epidemiology and Population Health, Chief, Division of Pediatric Infectious Diseases, Stanford University School of Medicine (USA)
Mary Marovich, Director Of Vaccine Research Program, NIAID, NIH
Giada Mattiuzzo, Senior Scientist, NIBSC
Luciana Maxim, Director, Quality and Impact (Research, Evidence and Learning); Lead, Polio Sample Transport, VillageReach
Diane McCarthy, Director, U.S. Pharmacopeia
Dr James McCarty, Clinical Professor of Pediatrics, Stanford University School of Medicine; Consultant, Emergent BioSolutions
Julie McElrath, Principal Investigator and Director, HVTN Laboratory Center, Director, Fred Hutchinson Cancer Research Center
Shelley Mclendon, Vice President, Vaccine and Infectious Disease, Icon
John McNally, Cold Chain Lead for Large Molecules, Johnson & Johnson
Monica Medina, Assistant Secretary for Oceans and International Environmental and Scientific Affairs, US Department of State
Robert Meehan, Senior Medical Director, Moderna Therapeutics
Jean-Cedric Meeus, Chief Global Transport, UNICEF
Matthew Memoli, Director, NIAID-NIH
Gustavo Mendes Lima Santos, General Manager, Medicines and Biological Products, Anvisa
Nelson Michael, Director, Center for Infectious Disease Research, Walter Reed Army Institute of Research
Michael Miller, Health Care & Life Sciences Consultant, HealthPolCom
Jacqueline Miller, Senior Vice President, Therapeutic Area Head, Infectious Disease, Moderna Therapeutics
Kayvon Modjarrad, Director, Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research
Joanne Monahan, Senior Vice President Of Vaccines Business Unit Lead, Merck
Emanuele Montomoli, Professor In Public Health University Of Siena And Chief Scientific Officer, vismederi
Pedro Moro, Epidemiologist, Centers for Disease Control and Prevention
Flor Munoz-Rivas, Assistant Professor Of Pediatrics-Infectious Disease, Baylor College of Medicine
Shankar Musunuri, Chairman, Chief Executive Officer and Co-founder, Ocugen
Tanya Myers, Epidemiologist, Co-Lead – V-Safe, Centers for Disease Control and Prevention
Yoshinobu Nagamine, Senior Manager, Gavi
Narayan Nair, Director, Division of Epidemiology, U.S. Federal Drug Administration
Piergiuseppe Nestola, Global Vaccine Technology Consultant, Sartorius Stedim Biotech
Kathy Neuzil, Professor in Vaccinology and Director, University of Maryland School of Medicine
Mark Newman, CSO, GeoVax, Inc.
Antonina Nikolova, Senior Director, CATO SMS — Pharm-Olam
Trisha Novy, Vice President of Medical Affairs, Dynavax Technologies
Jennifer Nuzzo, Professor of Epidemiology Inaugural Director, Pandemic Center, Brown University School of Public Health
Tim O'Donnell, Research Scientist, Tisch Cancer Institute Mount Sinai
Derek O'Hagan, Senior Advisor In R&D, GSK Vaccines
Saad Omer, Professor of Medicine, Yale Institute for Global Health
Eng Eong Ooi, Professor, Duke-NUS Graduate Medical School
Dinja Oosterhoff, Program Director, Intravacc
Ab Osterhaus, Director, Research Center For Emerging Infections And Zoonoses (Riz), University of Veterinary Medicine Hannover
Jenny Ottenhoff, Senior Policy Director, The ONE Campaign
Inna Ovsyannikova, Professor Of Medicine, Mayo Foundation For Medical Education and Research
Mark Page, Principal Scientist, NIBSC
Rolando Pajon, Director, Moderna Therapeutics
Lori Panther, VP, Clinical Development, Infectious Diseases, Moderna Therapeutics
Anant Patkar, Senior Director, Technical and Business Operations, Ligand
Gabriela Paz-Bailey, Chief of the Dengue Branch, CDC
Mikkel W. Pedersen, Chief Scientific Officer, Nykode
Yomaris Pena, Chief Medical Officer, SOMOS Community Care
Will Penny, Regional Account Manager & Application Scientist, Wyatt Technology Corporation
Luisa Perez, Network Provider, SOMOS Community Care
Gerald Pier, Professor of Medicine, Brigham and Women's Hospital
Robert Pierce, Chief R&D Officer, Sensei Bio
Amy Pisani, Executive Director, Vaccinate Your Family
Anel Pla, vp of communication, SOMOS Community Care
Stanley Plotkin, Emeritus Professor, University of Pennsylvania School Of Medicine
Paula Pohja-Hutchinson, Global Policy Director COVID-19 vaccine, AztraZeneca
Gregory Poland, Director Of Mayo Vaccine Research Group, Mayo Clinic
Alexander Roberto Precioso, Director of the Clinical Safety and Risk Management Center, Butantan Institute
Brian Price, Business development, Blue Water Vaccines
Kirk Prutzman, Primary Reviewer/RPM, FDA
Lisa Purcell, Senior Vice President, Microbiology and Virology, Vir Biotechnology, Inc.
Huma Qamar, AVP, Clinical Development, Ocugen
Patrick Raber, Director, Adaptive Biotechnologies
Mitsu Rana, Senior Director, Project Management, ICON plc
Sneha Rangarajan, Senior Scientist PD, IDT Biologika
Dirk Redlich, Vice President, Head CMC Development and Clinical Trial Material (CTM), Janssen Pharmaceutical
Josh Reece, Senior Director, Emergent BioSolutions
Guy Reeves, Researcher, Department for Evolutionary Genetics, Max Planck Institute For Evolutionary Biology
Juergen Richt, Director, Kansas State University
Craig Roberts, VP, Vaccines, Center for Observational and Real-World Evidence, Merck
Kari Roberts, Business Development Manager, Microbiologics Inc
Jim Robinson, LumaCyte Scientific Advisory Board, Consultant
Dirk Roymans, Managing Director, DNS Life Sciences Consulting
Charles Rupprecht, Director, LYSSA LLC
Kevin Russell, Associate Vice President, Merck
Jerry Sadoff, Senior Advisor, Janssen
Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Vaccines & Prevention B.V.
Sushant Sahastrabuddhe, Director, Enteric Fever, International Vaccine Institute
Michael Salgaller, Supervisor, Invention Development And Marketing Unit, National Cancer Institute - NIH
Dr Michael Santos, Vice President, FNIH
Gautam Sanyal, Principal Consultant and Founder, Vaccine Analytics
Niranjan Sardesai, President & Chief Executive Officer, Founder, Geneos Therapeutics
Sriram Sathy, CSO, Codiak BioSciences
Souleymane Sawadogo, Vice President of Global Health, Parsyl, Parsyl
Claire Scanlan, Process Development Scientist (PDS) & Manager, East Coast PDS region, Technical and Scientific Solutions (TSS) Group, MilliporeSigma
Mark Schleiss, Professor, University of Minnesota
Steven Schmid, Sr. Director Laboratory Strategic Planning and Dev, Clinical Trials of Texas, LLC
Kirsten Schneider-Ohrum, Vaccine Development Leader - CMV, GSK Vaccines
Hanneke Schuitemaker, Vice President And Head Of Viral Vaccine Discovery And Translational Medicine, Janssen
Shite Sebastian, Sr. Vice President, Affinivax
Darin Seehafer, Executive Director, Vaccines and EID, Syneos Health
Rafick-Pierre Sékaly, Professor and Vice-Chair of Translational Medicine, Emory University - School of Medicine
Casey Selwyn, Special Initiatives Lead & Senior Officer, Bill and Melinda Gates Foundation
Alessandro Sette, Center Head, Division Head, And Professor,, La Jolla Institute for Allergy and Immunology
Albert Shaw, Professor Of Medicine (Infectious Diseases), Yale University
Dong Shen, Chief Executive Officer & Founder, RNAimmune
Jim Sherner, Head of US Policy, Advocacy, and Government Affairs at Seqirus, Seqirus
Lora Shimp, Director - Immunization Center, John Snow Inc
Vivek Shinde, Vice President, Clinical Development Lead, Older Adult Influenza & RSV Vaccines, Novavax
Mariângela Simao, Assistant Director-General, WHO
William Smith, PI/Chief Executive Officer, Alliance for Multispecialty Research LLC
Daniel Smith, Global Vaccination Director, BD Medical
Igor Smolenov, Senior Vice President, Clover Biopharmaceuticals
Ronald Soriano, Field Application Scientist, Malvern Panalytical
Konrad Stadler, Chief Scientific Officer, Viroclinics-DDL
Stacey Stein, Director of Business Development, Syneos Health
Judy Stewart, Senior Vice President, GSK
Daniel Stoughton, Program Officer, National Institutes of Health
Walter Straus, Vice-President, Clinical Safety Lead, Moderna Therapeutics
Anusha Streubel, Executive Medical Director, Global Product Development, Vaccines, PPD, part of Thermo Fisher Scientific
Laurent Strodiot, Senior Manager, GSK Vaccines
Terrence Stull, President, BacVax
Rajinder Suri, Chief Executive Officer, Developing Countries Vaccine Manufacturers Network
Mandy Swann, Clinical Project Manager, Carilion Clinic
Adel Talaat, Professor Of Microbiology, University of Wisconsin-Madison
Ramon Tallaj, Founder and Chairman, SOMOS Community Care
Sybil Tasker, CMO, Codagenix Inc.
Kimberly Taylor, Senior Scientific Officer, Concept Accelerator Program- Vaccines, NIAID
Petro Terblanche, Managing Director, Afrigen Biologics
Stephen Thomas, Chief, Division Of Infectious Diseases, New York Upstate Medical University
Steve Thorne, Chief Scientific Officer, Kalivir Immunotherapeutics
Ian Thornton, Co-Chair, Covid-19 Vaccine Global Market Assessment Group, UNICEF
Gregory Tobin, Chief Executive Officer, Biological Mimetics, Inc.
Frank Tomaka, Senior Director, Clinical Lead HIV/STI Vaccines, Janssen Vaccines & Prevention B.V.
Adrian Towse, Director Emeritus and Senior Research Fellow, Office of Health Economics
Vu Truong, Chief Executive Officer And Chief Scientific Officer, Aridis Pharmaceuticals
Anastassia Tselikova, Research Scientist, Cell and Gene Therapy, FUJIFILM Irvine Scientific
Sean Tucker, CSO, Vaxart
Kumaran Vadivelu, Vice President, Vaccine Development Team Leader, GSK
Andrew Vaillant, Chief Scientific Officer, Replicor Inc.
Livio Valenti, Co-founder, Senior VP of Strategy, Operations and Business Development, Vaxess Technologies, Inc
Robert van den Berg, Head Data Sciences and Computational Vaccinology, GSK
Jolieke van Oosterwijk, Chief Science Officer, US Biologic
Marc Van Pruijssen, Director Global Logistics, Viroclinics-DDL
Vijetha Vemulapalli, Senior Director, Data Science, Genocea Biosciences
Katya Vert-Wong, Vice-President of Research & Development Operations, Sabin Vaccine Institute
Lidia Virgil, Chief Operating Officer, SOMOS Community Care
Dr Laura Walker, Chief Scientific Officer, Adagio Therapeutics
Linda Xiang Wang, Clinical Studies Coordinator, Medicago
Brian Ward, Medical Officer, Medicago
James Wassil, Chief Operating Officer, Vaxcyte
Patrick Wedlock, Global Health Program Lead, System Inc.
David Weiner, VP, Director of Vaccine & Immunology Center, The Wistar Institute
Annelies Wilder-Smith, Professor of Emerging Infectious Diseases, LSHTM; Consultant, Initiative of Vaccine Research, WHO
Jamie Wilkins, Head, Risk Management Center of Excellence (RMCoE), Pfizer
Dr Daniel Wolfe, Project Officer, Biomedical Advanced Research And Development Authority
Mitchell Wolfe, Chief Medical Officer, CDC
Larry Wolfraim, Cheif, Vaccine Section, Office of Biodefense, NIAID/NIH
Todd Wolynn, Chief Executive Officer And President, Kids Plus Pediatrics
Lauren V Wood, Chief Medical Officer, P.D.S. Biotechnology Corp
Jon B. "Ben" Woods, Senior Medical Advisor, FHI Clinical
Khaled Yamout, Senior Director Quality Control, TriLink BioTechnologies
Inkyu Yoon, Acting Director & Global Head of Programmes and Technology, CEPI
Alan Young, Chief Technology Officer, Medgene Labs
Xuefeng Yu, Chief Executive Officer, CanSino Biologics Inc.
Kalvin Yu, Medical Director, Medical Informatics, BD Insights Life Sciences
Darin Zehrung, Global Program Leader, Medical Devices And Health Technologies, PATH
Larry Zeitlin, President, Mapp Biopharmaceutical, Inc.
Konstantin Zeldovich, Head of Computational Antigen Design, Sanofi
Wei Zheng, Director, Moderna
Paul Zielinski, Executive Director, Federal Laboratory Consortium For Technology Transfer
Todd Zion, President & Chief Executive Officer, Chairman of the Board, AKSTON BIOSCIENCES CORPORATION
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events